Arena Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 75   

Articles published

ARNA 4.15 +0.04 (0.97%)
price chart
Arena Pharmaceuticals Provides Corporate Update and Reports Second ...
SAN DIEGO, Aug. 1, 2014 /PRNewswire/ -- Arena Pharmaceuticals, Inc. ARNA, -0.91% today provided a corporate update and reported financial results for the second quarter ended June 30, 2014.
Arena Pharmaceuticals Posts Increased Revenue In Second Quarter  Bidness Etc
Related articles »  
Concerns on Biotech Stocks- Arena Pharmaceuticals, Inc. (NASDAQ:ARNA ...
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) [Trend Analysis] recently delivered Belviq sales of $3.5M (including $0.4 million from the 15-day free trial voucher redemption).
Related articles »  
Traders Watch List -Arena Pharmaceuticals, Inc.(NASDAQ:ARNA) ,Aeropostale ...
Arena Pharmaceuticals, Inc.(NASDAQ:ARNA) declined 2.84% and closed at $4.11 in the last trading session with the total traded volume of 5.51 million shares.
Stocks in News : Arena Pharmaceuticals (NASDAQ:ARNA), AT&T (NYSE:T ...  Crazy Joys
Related articles »  
Stocks Alert: MannKind Corporation (NASDAQ:MNKD), Arena Pharmaceuticals ...
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)'s shares closed at $4.23. The company on Aug. 1 provided a corporate update and reported financial results for the second quarter ended June 30, 2014.
Related articles »  
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Dips As Loss Goes Beyond ...
Dallas, Texas 08/05/2014 (FINANCIALSTRENDS) - Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) reported a loss of 3.7% in its second quarterly results.
Arena Pharmaceuticals Falls on Wider-than-Expected Q2 Loss - Analyst Blog  NASDAQ
Related articles »  
Arena Pharmaceuticals Receives Consensus Rating of �Hold� from Brokerages ...
Arena Pharmaceuticals (NASDAQ:ARNA) last announced its earnings results on Friday, August 1st. The company reported $0.03 earnings per share for the quarter, beating the analysts' consensus estimate of ($0.11) by $0.14.
Volatile Stocks to Watch - dELiA*s, Inc.(NASDAQ:DLIA),Arena Pharmaceuticals ...  Techsonian (press release)
Related articles »  
Notable Movers:Arena Pharmaceuticals, Inc. (ARNA), TriQuint Semiconductor ...
Arena Pharmaceuticals, Inc.(NASDAQ:ARNA) reported the gain of 0.71% and closed at $4.23with the total traded volume of 4.39 million shares.
What Do Today's Gains Represent For These Companies? Arena ...  NIS
Special News Alert: OncothyreonInc (USA) (NASDAQ:ONTY), Ariad ...  Market News Call
Related articles »  
Trending Stocks: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Net Element ...
On 1 AUG Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) issued its quarterly earnings data on Friday. The company reported $0.03 earnings per share for the quarter, beating the analysts' consensus estimate of ($0.11) by $0.14.
Stocks Roundup - Arena Pharmaceuticals, Inc. (ARNA), Eli Lilly and Co (LLY ...
Las Vegas, NV - Aug 23, 2014 - (TechSonian) - ValuePennyStocks.com provides investors and traders with valuable trading tools and content as well as micro-cap stock alerts via eMail and text messages.
Related articles »  
Small Cap Obesity Stock Orexigen Therapeutics (OREX) Awaits Its Fate (ARNA ...
Small cap biotech Orexigen Therapeutics, Inc (OREX) is developing an obesity drug with a FDA Prescription Drug User Fee Act (PDUFA) action date set for September 11 plus a look at the so-so performance of obesity stocks Arena Pharmaceuticals, Inc ...